Product Information
Name:
Verdinexor
Description:
Verdinexor is an antibody-based therapeutic that targets the fatty acid binding protein (FABP) receptor, which is expressed at high levels in cancer cells. It has been shown to inhibit the proliferation of cervical cancer cells and induce apoptosis. Verdinexor also binds to epidermal growth factor and prevents its interaction with the FABP receptor. This drug has minimal toxicity and can be administered intravenously or subcutaneously, making it a promising therapeutic for patients with hematopoietic cancers.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
442.32 g/mol
Formula:
C18H12F6N6O
Purity:
Min. 95%
InChI:
InChI=1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4-
InChI key:
InChIKey=OPAKEJZFFCECPN-XQRVVYSFSA-N
SMILES:
O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
